Norethisterone (Norethisterone Lennon)
Norethisterone
Pharmacare limited û woodmead
Every registration of this product has been cancelled.
Registration
- Applicant
- Pharmacare limited û woodmead
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Norethisterone 5 MG tablets - lennon EACH TABLET CONTAINS NORETHISTERONE 5 mg | 5 mg -Tablets | R0012R/21.8.2/12 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Norethisterone
- when intended for parenteral use as a contraceptive;
- when intended for hormone replacement therapy;
- except when intended for oral contraception. (S3)
Consolidated Schedules 06 July 2026, lines 7321 to 7326
S3: Norethisterone
- when intended for oral contraception;
- except when intended for parenteral use as a contraceptive; (S4)
- except when intended for hormone replacement therapy. (S4)
Consolidated Schedules 06 July 2026, lines 4051 to 4057
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(8R,9S,10R,13S,14S,17R)-17-Ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
Drag to rotate. Structure from PubChem CID 6230.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.